TY - JOUR
T1 - A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
AU - Fuloria, Shivkanya
AU - Mehta, Jyoti
AU - Chandel, Aditi
AU - Sekar, Mahendran
AU - Rani, Nur Najihah Izzati Mat
AU - Begum, M. Yasmin
AU - Subramaniyan, Vetriselvan
AU - Chidambaram, Kumarappan
AU - Thangavelu, Lakshmi
AU - Nordin, Rusli
AU - Wu, Yuan Seng
AU - Sathasivam, Kathiresan V.
AU - Lum, Pei Teng
AU - Meenakshi, Dhanalekshmi Unnikrishnan
AU - Kumarasamy, Vinoth
AU - Azad, Abul Kalam
AU - Fuloria, Neeraj Kumar
N1 - Funding Information:
This study was funded by the Deanship of Scientific Research through Research Group (Small) (project number RGP.1/330/42) of the King Khalid University, Abha 61421, Saudi Arabia. The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Research Group (Small) (project number RGP.1/330/42). All the authors of this manuscript are thankful to their respective Departments/Universities for successful completion of this study. The figures in this manuscript were created with the support of https://biorender.com under a paid subscription (Ref: C08A1A0B-0002; 3 November 2021).
Funding Information:
This study was funded by the Deanship of Scientific Research through Research Group (Small) (project number RGP.1/330/42) of the King Khalid University, Abha 61421, Saudi Arabia. The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Research Group (Small) (project number RGP.1/330/42). All the authors of this manuscript are thankful to their respective Departments/Universities for successful completion of this study. The figures in this manuscript were created with the support of https://biorender.com under a paid subscription (Ref: C08A1A0B-0002; 3 November 2021).
Publisher Copyright:
Copyright © 2022 Fuloria, Mehta, Chandel, Sekar, Rani, Begum, Subramaniyan, Chidambaram, Thangavelu, Nordin, Wu, Sathasivam, Lum, Meenakshi, Kumarasamy, Azad and Fuloria.
PY - 2022/3/25
Y1 - 2022/3/25
N2 - Curcuma longa Linn. (C. longa), popularly known as turmeric, belongs to the Zingiberaceae family and has a long historical background of having healing properties against many diseases. In Unani and Ayurveda medicine, C. longa has been used for liver obstruction and jaundice, and has been applied externally for ulcers and inflammation. Additionally, it is employed in several other ailments such as cough, cold, dental issues, indigestion, skin infections, blood purification, asthma, piles, bronchitis, tumor, wounds, and hepatic disorders, and is used as an antiseptic. Curcumin, a major constituent of C. longa, is well known for its therapeutic potential in numerous disorders. However, there is a lack of literature on the therapeutic potential of C. longa in contrast to curcumin. Hence, the present review aimed to provide in-depth information by highlighting knowledge gaps in traditional and scientific evidence about C. longa in relation to curcumin. The relationship to one another in terms of biological action includes their antioxidant, anti-inflammatory, neuroprotective, anticancer, hepatoprotective, cardioprotective, immunomodulatory, antifertility, antimicrobial, antiallergic, antidermatophytic, and antidepressant properties. Furthermore, in-depth discussion of C. longa on its taxonomic categorization, traditional uses, botanical description, phytochemical ingredients, pharmacology, toxicity, and safety aspects in relation to its major compound curcumin is needed to explore the trends and perspectives for future research. Considering all of the promising evidence to date, there is still a lack of supportive evidence especially from clinical trials on the adjunct use of C. longa and curcumin. This prompts further preclinical and clinical investigations on curcumin.
AB - Curcuma longa Linn. (C. longa), popularly known as turmeric, belongs to the Zingiberaceae family and has a long historical background of having healing properties against many diseases. In Unani and Ayurveda medicine, C. longa has been used for liver obstruction and jaundice, and has been applied externally for ulcers and inflammation. Additionally, it is employed in several other ailments such as cough, cold, dental issues, indigestion, skin infections, blood purification, asthma, piles, bronchitis, tumor, wounds, and hepatic disorders, and is used as an antiseptic. Curcumin, a major constituent of C. longa, is well known for its therapeutic potential in numerous disorders. However, there is a lack of literature on the therapeutic potential of C. longa in contrast to curcumin. Hence, the present review aimed to provide in-depth information by highlighting knowledge gaps in traditional and scientific evidence about C. longa in relation to curcumin. The relationship to one another in terms of biological action includes their antioxidant, anti-inflammatory, neuroprotective, anticancer, hepatoprotective, cardioprotective, immunomodulatory, antifertility, antimicrobial, antiallergic, antidermatophytic, and antidepressant properties. Furthermore, in-depth discussion of C. longa on its taxonomic categorization, traditional uses, botanical description, phytochemical ingredients, pharmacology, toxicity, and safety aspects in relation to its major compound curcumin is needed to explore the trends and perspectives for future research. Considering all of the promising evidence to date, there is still a lack of supportive evidence especially from clinical trials on the adjunct use of C. longa and curcumin. This prompts further preclinical and clinical investigations on curcumin.
KW - Curcuma longa
KW - curcumin
KW - pharmacology
KW - phytochemical
KW - toxicology
UR - http://www.scopus.com/inward/record.url?scp=85129812912&partnerID=8YFLogxK
U2 - 10.3389/fphar.2022.820806
DO - 10.3389/fphar.2022.820806
M3 - Review Article
C2 - 35401176
AN - SCOPUS:85129812912
SN - 1663-9812
VL - 13
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 820806
ER -